Siren, L.L.C. Tango Therapeutics, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 3,364,814 shares of TNGX stock, worth $22.7 Million. This represents 0.89% of its overall portfolio holdings.
Number of Shares
3,364,814
Previous 2,565,342
31.16%
Holding current value
$22.7 Million
Previous $3.51 Billion
390.19%
% of portfolio
0.89%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
122Shares Held
117MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$114 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$72.6 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$71.9 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$61.9 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$40.8 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $595M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...